Regulatory Approval

Pharma veteran Pinder Sahota joins digital health firm Reset Health, signaling a strategic shift to integrated care in the new era of weight-loss drugs.

With a 135% revenue surge and a key FDA submission for its kidney transplant drug, Hansa Biopharma is poised for a pivotal year of expansion.

A wrongful death lawsuit alleges Abbott's FreeStyle Libre 3 sensor gave a fatal false reading, part of a massive recall affecting 3 million devices.

A deepened partnership between Crunchafi and Thomson Reuters promises to streamline complex lease accounting, offering new educational resources and integrated tools.

A new book offers a critical roadmap for medical device developers facing a storm of new AI regulations, complex FDA rules, and evolving IP law.

A new study finds most financial firms lack crypto trading policies, exposing them to major legal and reputational risks as global regulators intensify their crackdown.

With FDA Priority Review, Takeda's oveporexton could be the first drug to target the root cause of narcolepsy, offering transformative hope for patients.

A new report shows the carbon removal market has the tools to fight climate change, but widespread corporate inaction threatens to strand vital projects.

As drones become vital for first responders, Versaterm's new summit aims to tackle the complex regulatory, ethical, and operational challenges ahead.

Bolstered by a top regulatory expert and unique veterinary data, Vivos Inc. is set to file for human trials of its precision injectable cancer treatment.

ARS Pharma's neffy challenges the EpiPen with new data on efficacy, cost-effectiveness, and patient preference, promising a less intimidating allergy emergency.

In a major market shakeup, Dingdong is selling its China grocery operations to rival Meituan and plans to return the proceeds to shareholders.

Dayforce secures key ISO and NIST validations for its AI, signaling a new era of accountability and transparency in human resources technology.

Ahead of its first Climate Week, Mumbai's food innovators and activists gather to debate a sustainable future, proving the fight for the planet begins on our plates.

A new exchange launches hourly financial tools to help energy players manage ERCOT's extreme price volatility, promising more stability and innovation.

A new framework from LatticeFlow AI and Unique AI translates Swiss financial regulations into auditable code, paving the way for safer AI in banking.

A groundbreaking partnership in Italy is creating an AI-powered biobank to transform cancer diagnosis, promising faster, more accurate results for patients.

Starting next month, Dubai residents can hail autonomous vehicles on Uber as Baidu's Apollo Go service launches, accelerating the city's 2030 smart mobility goals.

Following a landmark FDA approval, IceCure Medical's long-serving CFO is exiting, placing the company at a pivotal financial crossroads for its new treatment.

With its IPO complete, Cambridge Acquisition Corp. enters a disciplined SPAC market with a clear focus on wellness, hemp, and psychedelic tech targets.